Literature DB >> 17082243

African ancestry, socioeconomic status, and kidney function in elderly African Americans: a genetic admixture analysis.

Carmen A Peralta1, Elad Ziv, Ronit Katz, Alex Reiner, Esteban González Burchard, Linda Fried, Pui-Yan Kwok, Bruce Psaty, Michael Shlipak.   

Abstract

Kidney disease is a major public health problem in the United States that affects African Americans disproportionately. The relative contribution of environmental and genetic factors to the increased burden of kidney disease among African Americans is unknown. The associations of genetic African ancestry and socioeconomic status with kidney function were studied cross-sectionally and longitudinally among 736 community-dwelling African Americans who were aged >65 yr and participating in the Cardiovascular Health Study. Genetic African ancestry was determined by genotyping 24 biallelic ancestry-informative markers and combining this information statistically to generate an estimate of ancestry for each individual. Kidney function was evaluated by cystatin C and estimated GFR (eGFR) using the Modification of Diet in Renal Disease equation. Longitudinal changes in serum creatinine and eGFR were estimated using baseline and follow-up values. In cross-sectional analyses, there was no association between genetic African ancestry and either measure of kidney function (P = 0.36 for cystatin C and 0.68 for eGFR). African ancestry was not associated with change in serum creatinine > or =0.05 mg/dl per yr (odds ratio [OR] 0.94; 95% confidence interval [CI] 0.83 to 1.06) or with change in eGFR > or =3 ml/min per 1.73 m(2) per yr (OR 1.02; 95% CI 0.92 to 1.13). In contrast, self reported African-American race was strongly associated with increased risk for kidney disease progression compared with white individuals for change in creatinine (OR 1.77; 95% CI 1.33 to 2.36) and for change in eGFR (OR 3.21; 95% CI 2.54 to 4.06). Among self-identified African Americans, low income (< US dollars 8000/yr) was strongly associated with prevalent kidney dysfunction by cystatin C >1.29 g/dl (adjusted OR 2.7; 95% CI 1.0 to 7.5) or by eGFR <60 ml/min per 1.73 m(2) (adjusted OR 3.2; 95% CI 1.1 to 9.4) compared with those with incomes >US dollars 35,000/yr. Alleles that are known to be present more frequently in the African ancestral group were not associated with kidney dysfunction or kidney disease progression. Rather, kidney dysfunction in elderly African Americans seems more attributable to differences in environmental and social factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082243     DOI: 10.1681/ASN.2006050493

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

1.  Poverty and racial disparities in kidney disease: the REGARDS study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; George Howard; Nataliya Volkova; Paul Audhya; David G Warnock
Journal:  Am J Nephrol       Date:  2010-05-31       Impact factor: 3.754

2.  Genetic African Ancestry and Markers of Mineral Metabolism in CKD.

Authors:  Orlando M Gutiérrez; Afshin Parsa; Tamara Isakova; Julia J Scialla; Jing Chen; John M Flack; Lisa C Nessel; Jayanta Gupta; Keith A Bellovich; Susan Steigerwalt; James H Sondheimer; Jackson T Wright; Harold I Feldman; John W Kusek; James P Lash; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-08       Impact factor: 8.237

3.  Comparison of statistical methods for estimating genetic admixture in a lung cancer study of African Americans and Latinos.

Authors:  Melinda C Aldrich; Steve Selvin; Helen M Hansen; Lisa F Barcellos; Margaret R Wrensch; Jennette D Sison; Charles P Quesenberry; Rick A Kittles; Gabriel Silva; Patricia A Buffler; Michael F Seldin; John K Wiencke
Journal:  Am J Epidemiol       Date:  2008-09-12       Impact factor: 4.897

4.  Association Between Income Disparities and Risk of Chronic Kidney Disease: A Nationwide Cohort Study of Seven Million Adults in Korea.

Authors:  Tae Ik Chang; Hyunsun Lim; Cheol Ho Park; Connie M Rhee; Kamyar Kalantar-Zadeh; Ea Wha Kang; Shin-Wook Kang; Seung Hyeok Han
Journal:  Mayo Clin Proc       Date:  2020-02       Impact factor: 7.616

5.  The Association of African Ancestry and elevated creatinine in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Carmen A Peralta; Neil Risch; Feng Lin; Michael G Shlipak; Alex Reiner; Elad Ziv; Hua Tang; David Siscovick; Kirsten Bibbins-Domingo
Journal:  Am J Nephrol       Date:  2009-12-21       Impact factor: 3.754

6.  Ethnic differences in anemia among patients with diabetes mellitus: the Diabetes Study of Northern California (DISTANCE).

Authors:  Ameena T Ahmed; Alan S Go; E Margaret Warton; Melissa M Parker; Andrew J Karter
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

Review 7.  The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.

Authors:  Janice P Lea; Keith Norris; Lawrence Agodoa
Journal:  Am J Nephrol       Date:  2008-04-24       Impact factor: 3.754

8.  Prevalence and Correlates of CKD in Hispanics/Latinos in the United States.

Authors:  Ana C Ricardo; Michael F Flessner; John H Eckfeldt; Paul W Eggers; Nora Franceschini; Alan S Go; Nathan M Gotman; Holly J Kramer; John W Kusek; Laura R Loehr; Michal L Melamed; Carmen A Peralta; Leopoldo Raij; Sylvia E Rosas; Gregory A Talavera; James P Lash
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-28       Impact factor: 8.237

9.  Genetic ancestry, social classification, and racial inequalities in blood pressure in Southeastern Puerto Rico.

Authors:  Clarence C Gravlee; Amy L Non; Connie J Mulligan
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

10.  Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis.

Authors:  Dimitrios Daoussis; Vasileios Panoulas; Tracey Toms; Holly John; Ioannis Antonopoulos; Peter Nightingale; Karen M J Douglas; Rainer Klocke; George D Kitas
Journal:  Arthritis Res Ther       Date:  2009-07-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.